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Abstract. In the present study, we have assessed the biophysical properties of lipid rafts from different brain areas in subjects
exhibiting early neuropathological stages of Alzheimer’s disease (AD). By means of steady-state fluorescence polarization
analyses using two environment-sensitive fluorescent probes, we demonstrate that lipid rafts from cerebellum, and frontal
and entorhinal cortices, exhibit different biophysical behaviors depending on the stage of the disease. Thus, while membrane
anisotropies were similar in the cerebellum along stages, lipid rafts from frontal and entorhinal cortices at AD stages I/II and
AD III were significantly more liquid-ordered than in control subjects, both at the aqueous interface and hydrophobic core of
the raft membrane. Thermotropic analyses demonstrated the presence of Arrhenius breakpoints between 28.3–32.0◦C, which
were not influenced by the disease stage. However, analyses of membrane microviscosity (ηapp) demonstrate that frontal and
entorhinal lipid rafts are notably more viscous and liquid-ordered all across the membrane from early stages of the disease. These
physicochemical alterations in lipid rafts do not correlate with changes in cholesterol or sphingomyelin levels, but to reduced
unsaturation index and increased saturate/polyunsaturated ratios in phospholipid acyl chains. Moreover, we demonstrate that -
secretase/APP (amyloid- protein precursor) interaction and lipid raft microviscosity are strongly, and positively, correlated in
AD frontal and entorhinal cortices. These observations strengthens the hypothesis that physical properties of these microdomains
modulate the convergence of amyloidogenic machinery toward lipid rafts, and also points to a critical role of polyunsaturated
fatty acids in amyloidogenic processing of APP.
Keywords: BACE1, -secretase, cerebellum, docosahexaenoic acid, entorhinal cortex, fluorescence anisotropy, frontal cortex,
lipid rafts, membrane viscosity, polyunsaturated fatty acids
∗Correspondence to: Dr. Mario Diaz, U.D.I. Fisiologı́a Animal,
Departamento de Biologı́a Animal, Universidad de La Laguna,
38206 Tenerife, Spain. Tel.: +34 922318343; Fax: +34 922318342;
E-mail: madiaz@ull.es.
INTRODUCTION
Compelling evidence accumulated over the last two
decades has pointed to lipid rafts, highly dynamic
membrane assemblies enriched in cholesterol, and sph-
ingolipids, as critical membrane domains involved
in the regulation of APP (amyloid- protein pre-
cursor) processing, and in the generation of the
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amyloid- (A) peptide, considered the driving
force in Alzheimer’s disease (AD) pathology [1–5].
Although the majority of full-length APP is com-
partmentalized to non-raft regions, an important subset
of APP partitions into lipid rafts along with BACE1
and -secretase components [4–6]. Integration of these
membrane proteins into lipid rafts is determined by
their capacity to establish specific protein-lipid interac-
tions. Thus, both BACE1 and the -secretase subunits
undergo posttranslational S-palmitoylation which aids
their targeting to lipid raft domains [4, 6]. Fur-
thermore, APP contains a transmembrane domain
resembling properties of canonical CRAC (Choles-
terol Recognition/interaction Amino acid Consensus
sequence) [7, 8], which allows the direct interaction
with cholesterol—the major lipid component of lipid
rafts [4, 7]. Additionally, Bhattacharyya et al. [9] have
recently reported that a fraction of APP undergoes
post-translational palmitoylation and that this lipid-
modified APP is specifically enriched in lipid rafts.
The singular lipid structure of lipid rafts makes
them liquid-ordered domains because the highly sat-
urated phospholipid (including sphingomyelin) acyl
chains and high cholesterol contents, enable closer
lipid packing and rather restricted lateral movement,
than in the surrounding non-raft regions [10]. Mul-
tiple lines of evidence, mostly based on selective
lipid depletion in cultured cells, have suggested that
these physicochemical features of lipid rafts pro-
vide the favorable environment for the amyloidogenic
processing of APP by altering the clustering dynam-
ics of APP-cleaving enzymes (reviewed in [1–5]).
However, whether these alterations occur during the
neuropathological progression leading to AD remain
largely unknown.
Recently, we have demonstrated that lipid rafts from
frontal cortex in late stages of Alzheimer’s disease
(Braak and Braak staging V/VI) display altered lipid
profiles compared to control subjects [11]. Most lipid
alterations were detected in the fatty acid composition
of phospholipids, rather than in the raft lipid prototyp-
ical lipid classes cholesterol or sphingomyelin [11].
More recently, we have reported that alterations in
lipid composition of lipid rafts from human cortex
are detectable from very early stages of the disease,
namely Braak and Braak stages I/II, where amyloid
plaques and cognitive symptoms are still absent [12].
In these lipid rafts, we found complex lipid changes
taking place in entorhinal and frontal cortices, but not
in cerebellum, consistent with both, reduction in long
chain polyunsaturated fatty acids (LCPUFA) in phos-
pholipids, and moderate cholesterol depletion, which
were accompanied by increased interaction of APP
and BACE [12]. These changes in the lipid matrix of
lipid rafts are expected to impact their physicochemical
properties and to alter membrane microdomain envi-
ronment during AD progression, which might facilitate
the co-segregation of APP and BACE, eventually
leading to increased A production.
Therefore, in the present study we have aimed to
explore 1) the impact of lipid changes in lipid rafts
during early stages of AD neuropathology, on the
biophysical properties of lipid rafts, and 2) the pos-
sible relationships between biophysical changes and
the convergence and association of proteins involved
in the amyloidogenic processing of APP.
MATERIALS AND METHODS
Human brain tissue and lipid rafts isolation
Brain tissues were obtained from the Institute of
Neuropathology Brain Bank (Bellvitge University
Hospital, Spain) following the guidelines of the Hos-
pital Ethics Committee. Based on neuropathological
examination, 12 cases were classified into three cate-
gories according to Braak and Braak [13]: AD stages
I/II (AD I group, average age 60.7 ± 2.9 years, of which
one case was AD II), AD stage III (AD III group, aver-
age age 74.7 ± 3.2 years), and controls (CTRL group,
average age 49.2 ± 4.64 years). A summary of all cases
is shown in Table 1. With the sole exception of subject
12, all cases were males. Regarding amyloid pathology,
only one case (subject 7, staged I/A) displayed senile
plaques in the neocortex (amyloid pathology stage A).
Importantly, cases in this study were selected based
on the results of our previous study aimed to deter-
mining the potential alterations of lipid composition
of lipid rafts in early stages of AD [12]. Therefore, in
doing this, it was possible to establish the precise bio-
physical correlates of lipid alterations. In every case,
frontal cortex grey matter (area 8), entorhinal cortex,
and cerebellar vermis were carefully dissected and sep-
arated from the subcortical white matter immediately
at autopsy, and stored at −80◦C until use for lipid rafts
isolation.
Lipid raft fractions were isolated following proce-
dures adapted for human brain lipid rafts detailed in
Martı́n et al. [11] and Ramı́rez et al. [14]. Fractions in
the gradients were routinely tested for purity in western
blot assays using different lipid raft and non-raft pro-
tein markers (i.e., anti-flotillin 1 and anti-caveolin-1 for
lipid rafts, anti-1 Na+/K+ ATPase subunit for non-
raft plasma membrane, and anti-Hsp90 for cytosolic
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Table 1
Summary of cases included in the study
Case Age Gender Postmortem delay Neuropathology
Control group
1 40 Male 5 h 10 min NL
2 44 Male 6 h 40 min NL
3 52 Male 3 h NL
4 61 Male 3 h 50 min NL
AD I/II group
5 67 Male 7 h 15 min II/0
6 61 Male 3 h 40 min I/0
7 53 Male 6 h 15 min I/A
8 62 Male 5 h 45 min I/0
AD III group
9 66 Male 2 h 45 min III/0
10 75 Male 5 h 30 min III/0
11 77 Male 6 h 20 min III/0
12 81 Female 1 h 30 min III/0
NL, no lesions. Neuropathology was classified according to Braak
and Braak stages of Alzheimer’s disease (stages I-III). 0-A indicates
stages of amyloid neuropathology.
proteins). Fractions containing lipid raft markers
flotillin-1 and caveolin-1 were collected, resuspended
in isolation buffer and frozen at −80◦C until analyses.
Lipid analyses
Analyses of lipid composition of lipid rafts fractions
was carried out as described previously by our group
for human brain [11, 12]. Total lipids were extracted
with chloroform/methanol (2:1 v/v) in the presence
of 0.01% of butylated hydroxytoluene. Lipid classes
were separated by one-dimensional double develop-
ment high performance thin layer chromatography
and quantified by densitometry. A fraction of total
lipids extracted from lipid rafts were subjected to acid-
catalyzed transmethylation to form the corresponding
fatty acid methyl esters (FAME) and dimethyl acetals
(DMA), which were purified by thin layer chromatog-
raphy (TLC) and quantified by gas chromatograph
using flame ionization detection and identified by mass
spectrometry.
Immunoprecipitation assays
Lipid raft fractions were processed for immuno-
precipitation as described in Fabelo et al. [12].
Briefly, fractions diluted in immunoprecipitation
buffer (50 mM Tris-HCl pH 7.4; 150 mM NaCl,
10% glycerol, 1% Nonidet-P 40, 1 mM PMSF, and
Roche’s proteases inhibitor cocktail) were solubilized
in 2% octyl -D-glucopyranoside solution containing
Na3VO4 and EDTA, and immunoprecipitated with an
excess (5 g) of rabbit polyclonal anti-APP antibody
(Y-188, Abcam) overnight at 4◦C. Samples were then
exposed to sheep anti-rabbit IgG dynabeads (Dynal).
The resultant precipitated protein-dynabead immuno-
complexes were disrupted using SDS loading buffer
and resolved in 12.5% SDS-PAGE followed by western
blotting. Proteins were then transferred to Hybond-P
and blotted with rabbit anti-BACE polyclonal antibody
(Chemicon International), and rabbit anti-Presenilin
1 antibody (Sigma-Aldrich), both diluted 1:500 in
BLOTTO. Visualization of specific immunosignals
developed for anti-rabbit horseradish peroxidase-
conjugated secondary antibodies (diluted 1:10,000 in
BLOTTO) were obtained with ECL chemilumines-
cence kit (Amersham, GE Healthcare). Densitometry
values of specific signals were quantified using GS-
800 calibrated densitometer (Bio-Rad, Madrid, Spain).
Relative values of BACE immunosignals were normal-
ized to the total APP content quantified in the same
sample.
Steady-state fluorescence anisotropy of lipid rafts
Steady-state anisotropy (rs) measurements were
performed using two different fluorescent probes:
nonpolar 1,6-diphenyl-1,3,5-hexatriene (DPH) and
polar 1-[4-(trimethylammonium)phenyl]-6-phenyl-
1,3,5-hexatriene (TMA-DPH). DPH and TMA-DPH
were dissolved in 1 tetrahydrofuran:1 ethanol (v/v)
and stored as 200 M stock solutions. Fluorescent
probes were used at 2 M in TBS (20 mM Tris–HCl
buffer, pH 7.5, containing 150 mM KCl) prepared
daily and stored protected from light until used. Lipid
raft suspensions (250 L, 50 g protein/mL) were
incubated for 30 min at 37◦C in PBS solutions labelled
with the probes and under agitation. Fluorescence
polarization values were determined using 355 nm
excitation and 420 nm emission filters in an Appliskan
multiplate reader (Thermo Scientific) equipped with
polarizers. Unlabeled controls were simultaneously
examined to correct for light scattering and intrinsic
fluorescence. Steady-state fluorescence anisotropies
were determined against temperature ramps from
20◦C to 40◦C.
In some experiments, lipid rafts samples were prein-
cubated with 5 mM methyl--cyclodextrine (MCD)
in TBS at 37◦C for 1 h, before incorporation of the
fluorescent probes.
Microviscosity and thermodynamic calculations
Membrane microviscosity, η, is the measure of fric-
tional resistance to rotational and translational motions
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of molecules within bilayers. Membrane microvis-
cosity (the reciprocal to membrane fluidity) can be
estimated by fluorescence anisotropy of rod-shaped
probes (as DPH or TMA-DPH), which reflects their
rotational motion inside the membrane [15, 16].
Because in lipid membranes rotational mobility of
these probes is not isotropic but restricted in space,
it also reflects the level of lipid order (or lipid pack-
ing) [15, 16]. These two parameters, microviscosity
and lipid order, discriminate different membrane phase
states, such gel and liquid-ordered (which are believed
to be responsible for functional lipid rafts domains),
and fluid phase (in non-raft domains). In the present
study, apparent microviscosity (ηapp) coefficients were
computed based on the adaptation of the Perrin equa-
tion for rotational depolarization of DPH [17] and
TMA-DPH [18] as described in Diaz et al. [19].
Discontinuity breakpoints (Td), which inform on the
temperature where phase transitions occur, and acti-
vation energies (Ea) for steady-state anisotropy were
computed from Arrhenius plots [20], being the slopes
of log(rs) or log(ηapp) versus 1/T equal to Ea/(2.3 R).
Flow activation energy or activation energy of viscous
flow (Eη) was derived by analogy to macroscopic fluids
from empirical determination of temperature depen-
dence of ηapp, being the slope of log(ηapp) versus 1/T
plots equal to Eη/(2.3 R) [16, 21].
Statistics
Data were submitted to two-way ANOVA or one-
way ANOVA followed by Student’s t-test, where
appropriate. Regression analyses were performed by
non-linear regression. Pearson correlation coefficients
(R) and their corresponding p-values were calculated
for all regression lines. Significance of regression
analyses was assessed by one way ANOVA. When
appropriate, 95% confidence intervals are indicated in
Figs. 3 and 4.
RESULTS
Thermotropic behavior of lipid rafts anisotropy
We have used two different probes, the nonpolar
probe DPH to determine the physical order at the
hydrophobic core of the lipid raft membrane, and
the polar TMA-DPH to assess rotational freedom at
the membrane plane [22, 23]. Results summarized in
Fig. 1A show the temperature response of TMA-DPH
steady-state anisotropy in lipid rafts from cerebellum
(CB), entorhinal cortex (EC), and frontal cortex (FC)
in the control, AD I/II, and AD III groups. Anisotropy
curves in the range 20–40◦C were fairly similar in
the cerebellum irrespective of the neuropathological
state, being the values measured at 37◦C nearly iden-
tical in the three groups (CB, F2 ,5 = 1.82, p > 0.1).
Conversely, in EC and FC, a clear upward shift in
anisotropy curves was evident for controls as compared
to AD groups, indicating that TMA-DPH anisotropies
in lipid rafts from AD subjects are inherently higher
in the whole range of temperatures than in control
rafts (EC: F2 ,5 = 2.31, p = 0.056; FC: F2 ,5 = 3.52,
p < 0.05). Arrhenius plots of steady-state TMA-DPH
anisotropies revealed the existence of thermotropic
phase transitions around discontinuity points (Td),
in the range 28.3–29.9◦C, which were quite similar
between brain areas and also between disease stages
(Fig. 1B). Similarly, computation of activation ener-
gies (Ea) below Td indicated no differences between
lipid rafts from either group.
Using a modified expression of Perrin equation for
non-spherical probes [18, 21], we have assessed the
changes in lipid raft microviscosity coefficients in the
different brain areas and conditions (Table 1). Apparent
microviscosity (ηapp) and flow activation energies (Eη)
in cerebellum were nearly constant (ηapp around 1.71
poises at 37◦C and Eη around 2.5 kcal/mol) and were
unaffected by the disease (Fig. 1C). On the contrary,
in EC and FC lipid rafts, ηapp values were significantly
higher (average 1.82 poises at 37◦C) at AD stages I/II
and III/IV than in controls (Table 1), but these changes
were not followed by changes in Eη, which remained
in the range observed for cerebellum (Fig. 1C).
The thermotropic behavior of raft membranes at
the internal core of the bilayers was assessed using
DPH [22, 23]. As in the case of TMA-DPH, lipid
rafts displayed temperature-induced changes in mem-
brane anisotropy, which were unaffected by the disease
stage in CB (CB, F2,5 = 0.84, p > 0.1), but differed in
EC and FC lipid rafts (EC: F2 ,5 = 5.53, p < 0.05; FC:
F2,5 = 13.85, p < 0.05). Thus, in cortical lipid rafts at
stages I/II and III, DPH anisotropies were significantly
higher in the whole temperature range as compared
to controls (Fig. 2A). In order to get a deeper insight
into the characterization of the mechanisms leading
to these changes, we also explored the effects of
cholesterol depletion in the same rafts using MCD.
The preincubation protocol with MCD used here
(5 mM for 1 h), causes a 50% depletion of membrane
cholesterol [24]. Treatment with MCD (+MCD)
brought about a considerable reduction of lipid raft
probe anisotropies in all groups compared with con-
trols (TBS), but the effects were more remarkable in
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Fig. 1. Biophysical characterization of lipid rafts from cerebellum, entorhinal cortex, and frontal cortex in CTRL, AD I/II, and AD III brains
probed with TMA-DPH. A) Temperature dependence of TMA-DPH fluorescence anisotropy of lipid rafts. B) Arrhenius plot for steady-state
anisotropy in lipid rafts in the different brain areas. Arrows indicate discontinuity points (Td in ◦C) and the range of activation energies (Ea
in kcal/mol) obtained below Td. C) Apparent microviscosity (ηapp ) analyses performed below Td based on the Perrin equation modified for
rod-shaped probes. Slopes indicate the activation energy of viscous flow (Eη).
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Fig. 2. Biophysical characterization of lipid rafts from cerebellum, entorhinal cortex, and frontal cortex in CTRL, AD I/II, and AD III brains
probed with DPH. A) Temperature dependence of DPH fluorescence anisotropy of lipid rafts treated with methyl--cyclodextrin (MCD, 5
mM) or without (TBS, TRIS-buffered saline). B) Arrhenius plot for steady-state anisotropy in lipid rafts in the different brain areas and in
the presence or absence of MCD. Arrows indicate the position of discontinuity points (Td in ◦C) and the range of activation energies (Ea in
kcal/mol) obtained below Td. C) Apparent microviscosity (ηapp ) analyses performed below Td. Slopes indicate the activation energy of viscous
flow (Eη).
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EC and FC rafts from AD subjects (CB: F2 ,5 = 1.89,
p > 0.1; EC: F2 ,5 = 34.30, p < 0.05; FC: F2 ,5 = 14.38,
p < 0.05) (Fig. 2A). Arrhenius plots for steady-state
DPH anisotropies also revealed the presence of dis-
continuity points in the range 29.2–30.7◦C (Fig. 2B)
which were shifted in all cases toward higher tem-
peratures by MCD (range 31.5–32.7◦C). However,
MCD treatment caused a dramatic increase in acti-
vation energies (Ea) below Td, which increased by
about 130% in CB lipid rafts. Moreover, In FC and EC
lipid rafts, the reduction in log (rs ) and the increase
in Ea induced by MCD were significantly higher
in controls than in AD stages (Fig. 2B). Paralleling
these changes in steady-state anisotropy, microviscos-
ity values (ηapp) were dramatically reduced by MCD
treatment in all cases, but the magnitude of changes
differed between controls and AD lipid rafts (Table 1).
Thus, in cerebellum, ηapp variations were very sim-
ilar between stages (average 1.03 poises at 37◦C in
TBS and 0.58 poises at 37◦C in MCD, represent-
ing a reduction of 43% or ηapp = −0.45 poises), and
these changes were equivalent in FC and EC lipid
rafts from control brains (average 1.01 poises at 37◦C
in TBS versus 0.52 poises at 37◦C in MCD, repre-
senting a 47% reduction and ηapp = −0.49 poises at
37◦C). However, in AD lipid rafts from FC and EC,
ηapp was significantly higher than in controls both
under TBS (average ηapp = +0.112 poises at 37◦C)
and MCD treatments (average ηapp = +0.117 poises
at 37◦C). Interestingly, ηapp values between TBS and
MCD in AD lipid rafts were in the range observed
for control rafts (ηapp = −0.47 poises at 37◦C). Fur-
ther, pretreatment with MCD led to a considerable
increase in Eη, which indicates that phase transitions
must occur against a larger energy gradient (Fig. 2C).
These differences are likely to reflect changes in the
rotational order of DPH inside the membrane core,
since DPH fluorescence and membrane depth location
are largely independent of membrane cholesterol [23].
Overall, these results demonstrate that, under normal
physiological conditions, lipid raft membrane viscos-
ity and membrane dynamics are largely determined
by its cholesterol content, and that lipid rafts from
EC and FC, but not from CB, are intrinsically more
viscous in AD brains from very early stages of the
disease.
Relationships between lipid raft lipids and
microviscosity
We next attempted to identify the biochemical cor-
relates of these differential biophysical behaviors of
lipid rafts, based on the alterations in their lipid pro-
files recently reported for these same subjects [12].
Using non-linear regression analysis, we assessed the
linear relationships between relevant lipid components
known to be altered in AD lipid rafts and ηapp vari-
ations (Fig. 3). First, using the whole dataset, we
explored the relationship between ηapp determined at
37◦C, and cholesterol or sphingomyelin contents as
independent variables (scatterplots in Fig. 3A, B). The
results revealed positive correlations for both lipid
constituents and ηapp, which were statistically signifi-
cant for cholesterol (TMA-DPH: R = 0.61, p < 0.015;
DPH: R = 0.37, p < 0.05) (Fig. 3A). However, when
lipid rafts data was structured according to disease
stages, a negative correlation was observed for choles-
terol (TMA-DPH: R = −0.89, p < 0.05; DPH: R = 0.72,
p < 0.1) and sphingomyelin (TMA-DPH: R = −0.50,
p > 0.1) (Fig. 3A, B, left plots), indicating that although
lipid raft microviscosities increased in FC and EC from
AD subjects, the alterations were not attributable to ele-
vation of cholesterol or sphingomyelin levels. Indeed,
we have observed that cholesterol contents in lipid rafts
from FC and EC from AD subjects were decreased
and, at least for FC, also those of sphingomyelin [12].
On the other hand, the phospholipid/cholesterol ratio
(scatterplot in Fig. 3C) was also found to be positively
related to ηapp (TMA-DPH: R = 0.30, p < 0.05; DPH:
R = 0.36, p < 0.05), which apparently falls in contra-
diction with the observation that increased cholesterol
content increases ηapp. Given these anomalies, it would
be expected that lipid rafts from FC and EC in AD were
more fluid than in controls, which is obviously not the
case.
The finding that phospholipid/cholesterol ratio was
positively related to ηapp, pointed out to alterations in
the degree of unsaturation of acyl chains in phospho-
lipids being responsible for the changes in membrane
microviscosity observed in lipid rafts from AD frontal
and entorhinal cortices. To test this hypothesis, we first
examined the relationship between unsaturation index
(UI) and lipid rafts microviscosity. The results showed
that reduction of UI is associated to significant increase
in ηapp, especially at the membrane aqueous inter-
face (TMA-DPH: R = 0.62, p < 0.005; DPH: R = 0.45,
p < 0.01) (Fig. 3D). As monoene fatty acids were unaf-
fected by AD in any tissue or stage [12], the most
likely factor accounting for the reduction in ηapp (and
UI) were LCPUFA (long-chain polyunsaturated fatty
acids). Accordingly, we observed a very significant
reduction of ηapp as a function of n-3 LCPUFA (TMA-
DPH: R = 0.55, p < 0.005; DPH: R = 0.54, p < 0.005)
(Fig. 3E), and more consistently between ηapp and
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Fig. 4. Relationships between apparent microviscosity (ηapp ) and amount of BACE1 and PSEN1 physically associated with APP, in lipid rafts.
A, B) Scatterplots for simultaneous determinations of ηapp , as determined at 37◦C using TMA-DPH (solid circles) and DPH (empty circles),
and BACE1 (A) and PSEN1 (B) immunoprecipated with APP, in the whole lipid rafts dataset. C, D) Regression analyses for the relationships
between APP-immunoprecipitated BACE1 (circles) and PSEN1 (diamonds), and lipid rafts microviscosity as probed with TMA-DPH (C) and
DPH (D), in the different brain areas and disease stages. Regression (solid) lines are indicated. In C, the two regression lines correspond to
frontal (CF, leftward line) and entorhinal cortex (EC, rightward line). 95% confidence intervals (dotted lines) are shown in the scatterplots. 95%
Confidence intervals are indicated in A, B, and D.
sat/n-3 LCPUFA (TMA-DPH: R = 0.62, p < 0.001;
DPH: R = 0.64, p < 0.001) (Fig. 3F).
Relationships between lipid raft microviscosity
and AβPP and β/γ-secretase clustering
We finally assessed for the potential involvement
of physicochemical alterations in lipid rafts on the
degree of physical association of APP and - and
-secretases. First, by means of immunoprecipitation
assays in the same lipid rafts, we observed that lipid
rafts from entorhinal and frontal cortices at stages
I/II and III, exhibit significantly increased degree of
association between BACE1 and APP (Table 2).
This augmented BACE1/APP interaction occurred
only in cortical lipid rafts, and was not detected in
lipid rafts from cerebellum at any stage of the dis-
ease (Table 2). Further, the interaction was specific
for BACE1 and was not observed for PSEN1 beyond
control values, which is in agreement with the alter-
ations recently reported for these same subjects [12].
Moreover, BACE1/APP interaction seemed to be
influenced by the lipid environment of lipid rafts since
a positive association was observed for the amount of
immunoprecipitated BACE1 (but not PSEN1) and lipid
raft microviscosity, especially at the aqueous interface
(TMA-DPH: R = 0.62, p < 0.001) and hydrophobic
core (DPH: R = 0.59, p < 0.001) of the membrane
(Fig. 4A, B). These relationships were extended to
the results obtained in lipid rafts from each brain area
and disease stage. The outcomes revealed that lipid
raft microviscosity was positively correlated to the
degree of BACE1/APP association in cortical areas,
but not in cerebellum. Indeed, lipid rafts from FC
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Table 2
Apparent microviscosity values (ηapp ) at 37
◦
C, calculated for the membrane plane and membrane hydrophobic core, as probed using TMA-DPH
and DPH, respectively, in lipid rafts from controls and AD subjects at neuropathological stages I/II and III
Brain area Stage TMA-DPH DPH
TBS MCD
Cerebellum Ctrl 1.706 ± 0.035 1.021 ± 0.029 0.588 ± 0.021
AD I/II 1.699 ± 0.036 1.040 ± 0.029 0.604 ± 0.016
AD III 1.714 ± 0.034 1.025 ± 0.030 0.546 ± 0.010
Frontal cortex Ctrl 1.748 ± 0.025 1.014 ± 0.030 0.541 ± 0.015
AD I/II 1.827 ± 0.038* 1.083 ± 0.028 0.659 ± 0.008*
AD III 1.865 ± 0.046* 1.132 ± 0.029* 0.647 ± 0.009*
Entorhinal cortex Ctrl 1.686 ± 0.026 1.002 ± 0.029 0.515 ± 0.012
AD I/II 1.805 ± 0.035* 1.105 ± 0.020* 0.605 ± 0.012*
AD III 1.775 ± 0.034* 1.160 ± 0.029* 0.671 ± 0.007*
Data were submitted to one way ANOVA followed by Student’s t-test for comparisons with Ctrl group. * p < 0.05 compared to Ctrl.
Table 3
Interactions of BACE1 and PSEN1 with APP in lipid rafts obtained
in brains from controls and AD subjects at neuropathological stages
I/II and III
Brain area Stage BACE1 PSEN1
Cerebellum Ctrl 1.10 ± 0.01 1.19 ± 0.04
AD I/II 1.23 ± 0.08 1.18 ± 0.10
AD III 1.21 ± 0.15 1.42 ± 0.12
Frontal cortex Ctrl 1.70 ± 0.25 1.54 ± 0.04
AD I/II 4.20 ± 0.63** 1.39 ± 0.09
AD III 4.26 ± 0.86** 1.28 ± 0.13
Entorhinal cortex Ctrl 1.81 ± 0.14 1.28 ± 0.04
AD I/II 5.58 ± 1.03*** 1.09 ± 0.13
AD III 3.67 ± 0.44* 1.10 ± 0.11
Data were submitted to ANOVA I followed by Student’s t-test for
comparisons with Ctrl group. *p < 0.05, **p < 0.01, and ***p < 0.005
compared to Ctrl.
and EC at stages I/II and III, displaying highest lev-
els of BACE1/APP interaction, are closely related
to largest apparent viscosity values, especially at the
membrane plane (Fig. 4C). Paralleling these findings,
APP/PSEN association behaved rather independently
of ηapp in lipid raft (Fig. 4C, D).
DISCUSSION
In the present study, we provide new evidence
that lipid rafts constitute subcellular targets seriously
affected in AD neurodegeneration. We show that even
at the earliest stages of AD, physicochemical prop-
erties of raft membranes from entorhinal and frontal
cortices exhibit severe alterations which might reflect
initial events in the progression of the disease. It
is widely accepted that lipid rafts are critical ele-
ments in the amyloidogenic processing of APP [2,
4–6], and that specific lipid alterations within these
domains accelerate A peptides generation thus facil-
itating aggregation [1, 3–5, 25]. However, the extents to
which these lipid changes affect biophysical properties
of lipid raft microenvironment and how this physic-
ochemical scenario affect the dynamics of amyloid
processing remain poorly understood.
By analyzing some of the biophysical properties
of lipid rafts from control subjects, we show that
lipid rafts from all brain areas display equivalent ther-
motropic behaviors, with phase transitions around a
discontinuity point at 29◦C, and similar activation ener-
gies between brain areas as measured above Td. This
homogeneity was observed both at the aqueous inter-
face and hydrophobic core of the lipid rafts, being
the viscosity of the internal core smaller and the flow
activation energy larger than at the aqueous interface.
These observations indicate a great degree of packing
of membrane phospholipids, which may provide more
abundant hydrophobic interactions between phospho-
lipid fatty acids in the membrane plane, as it has been
suggested in other membrane systems, including lipid
rafts [19, 26, 27]. However, in AD brains, we have
observed that lipid rafts membrane domains are dif-
ferentially affected by the disease stage depending on
the brain area considered. Thus, while cerebellar lipid
rafts exhibit nearly constant biophysical and biochem-
ical properties along AD neuropathological stages,
rafts from enthorhinal and frontal cortices develop
substantial changes in lipid composition that impact
their biophysical properties, particularly their micro-
viscosity. Strikingly, even at stages I/II, lipid rafts from
frontal and entorhinal cortices appear as more viscous
and liquid-ordered structures than in control counter-
parts. We also observed that these alterations project
the whole transversal section of the lipid bilayer. From
the neuropathological point of view, these findings are
relevant since entorhinal cortex, which is one of the
brain areas where neurofibrillary tangles first appear,
are devoid of amyloid plaques at stages I/II [13, 28].
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Therefore, biophysical changes must have occurred at
initial stages of AD neuropathology, well before amy-
loid burden.
We have recently reported that lipid rafts from
entorhinal and frontal cortices of stages I/II and
III, contain significantly lower levels of n-3 and n-
6 LCPUFA (specifically docosahexaenoic acid and
arachidonic acid, respectively), which, in turn, deter-
mine lower unsaturation and peroxidability indexes,
and higher saturates/n-3 and saturates/n-6 indexes [12].
Importantly, most of these modifications observed at
early stages are present, though to a different degree,
in advanced stages (IV/V) of AD [11]. Noticeably,
we have observed that lipid alterations also extend to
lipid classes, since lipid rafts from AD I/II and AD
III cortex display significantly lower cholesterol lev-
els as well as increased phospholipid/cholesterol ratio,
as compared to controls. The reasons for these wide
lipid alterations are currently unknown, but they sug-
gest that disruption of neuronal lipid homeostasis [2, 3,
29–31], concomitantly with oxidative damage of mem-
brane lipids [32–35], convey to overwhelm neuronal
capacity to adapt membrane biosynthetic/recycling
mechanisms needed to maintain lipid raft homeostasis.
It can be surmised that these biochemical changes
are likely to severely affect physicochemical microen-
vironment of lipid rafts. One strength in the present
study was that we have performed measurements of
biophysical features within the same lipid rafts where
we have previously identify lipid alterations associated
with early stages of AD [12], which allowed assess-
ment on the extent to which changes in each lipid
variable impacted membrane order. Thus, by analyzing
lipid raft data as a whole, we demonstrate that increas-
ing cholesterol or sphingomyelin contents in lipid rafts
causes the expected increase in membrane viscosity
[36–38], and that augmented levels of polyunsaturated
fatty acids or elevation of unsaturation index brings
about more fluid raft membranes [19, 39, 40]. Taken
together, our data indicate that the increased micro-
viscosity observed in lipid rafts from entorhinal and
frontal cortices in AD stages I/II and III, cannot be
attributed to changes in cholesterol or sphingomyelin
levels (which in fact were reduced in these rafts). In
agreement, we show that forced depletion of choles-
terol using MCD, provoked a considerable reduction
of microviscosity in lipid rafts from all origins, and
this effect was accompanied by a two-fold increase in
Eη, which highlights the central role of cholesterol in
setting the thermodynamic properties of liquid-crystal
phase characteristic of ordered lipid rafts [37, 41].
Therefore, with cholesterol being reduced in untreated
FC and EC lipid rafts, but activation energies (Ea) and
flow activation energies (Eη) being similar to control
rafts, some sort of alternative mechanisms must have
been occurred to augment the microviscosity state of
these lipid rafts, likely involving other components in
the membrane lipid matrix. We found the explanation
on the reduction in the degree of unsaturation of lipid
raft phospholipids, specifically for n-3 LCPUFA, and
the proportional increase in the saturates/n-3 LCPUFA.
In agreement, best bivariate relationships for ηapp as
dependent variable were observed for n-3 LCPUFA
and saturates/n-3 LCPUFA relationship, especially at
the membrane plane. Interestingly, we have recently
demonstrated a very similar physicochemical behav-
ior in lipid rafts from frontal cortex of aged APP/PS1
transgenic mice, a familial model of AD [19, 42].
Therefore we conclude that lipid rafts from FC and
EC in AD brains are intrinsically more viscous and
ordered than in control subjects due to the depletion in
polyunsaturated fatty acids and the secondary increase
in saturates/n-3 LCPUFA ratio.
The pathological impact of the physiochemical alter-
ations discussed above was demonstrated by the study
of the dynamics of associations of proteins directly
involved in amyloid production in the same lipid rafts.
We had previously observed that BACE1 and PSEN
interact with APP at the raft membranes, even in con-
trol brains, but noticeably, that the degree of physical
association between APP and BACE1 was positively
modulated in FC and EC of AD brains, even at the earli-
est stages of the disease [12]. Here, we found that such
interaction occurs in consonance with changes in the
lipid raft microenvironment. Thus, simultaneous mea-
surements of BACE1 or PSEN1 immunoprecipitated
with APP and apparent microviscosity reveals that
the amount of BACE1 present in lipid rafts increases
linearly with ηapp, while the amount of PSEN1 in
lipid rafts remained unaltered. APP/BACE1 asso-
ciation was better correlated with the viscosity at
the aqueous interface than at hydrophobic core of
the bilayer, suggesting interactions of their respective
transmembrane segments with long chain saturated
fatty acids, which in turn are facilitated for inter-
action upon reduction of membrane phospholipids
polyunsaturation. Obviously, factors promoting phys-
ical contact between APP and -secretase within
rafts are expected to enhance CTF99 intermediate
formation and to increase substrate availability for
further cleavage by -secretase [5, 41, 43]. There-
fore, we postulate that it is the viscous lipid rafts
environment, rather than their lipid components them-
selves, what determines the ease of amyloidogenic
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processing of APP within rafts. In line with this
hypothesis, our present data are also reconciling in rela-
tion to conflicting evidence describing opposite effects
of cholesterol on the regulation of APP processing
[1, 3, 25]. Thus, it has been solidly demonstrated that
cholesterol enrichment increases membrane viscosity
[1, 37, 41], and this can explain the displacement of
APP processing toward the amyloidogenic cleavage
and A formation [5, 44, 45]. Conversely, work from
other laboratories have shown that neuronal membrane
cholesterol loss enhances amyloid peptide generation
[25, 46], and this, as we show here, may also be
associated to reduced membrane fluidity as long as
membrane unsaturation is concurrently decreased, thus
paving a favorable environment for amyloidogenic
APPc cleavage. Nonetheless, as we demonstrate in
the present study, the role of cholesterol in lipid
rafts extends well beyond changes of membrane flu-
idity, being also linked to thermodynamic behavior of
these microdomains, including setting of flow activa-
tion energies, determination of gel/liquid-crystalline
phase transition, and stabilization of sphingomyelin-
rich lipid matrix in the raft membranes.
The causes for the changes in the physicochem-
ical properties of lipid rafts in human brain cortex
at initial stages of AD neurodegeneration are cur-
rently unknown. Certainly, membrane microviscosity
is a homeostatic parameter resulting from complex
lipid interactions within the bilayer under the influ-
ence of physical parameters. The intricate lipid rafts
nanoscopic dynamics, suggest that lipid alterations
may well occur at different subcellular stages in the
biosynthetic pathway, from vesicle trafficking/sorting
and phase segregation at the trans Golgi network, to
phospholipid remodeling as consequence of acyla-
tion/deacylation mechanisms [47–49]. However, given
that one major determinant in the biophysical alter-
ations observed here is the depletion in phospholipid
polyunsaturation, it is tempting to speculate that
either (lipo)peroxidative mechanisms alter the satu-
rated/unsaturated equilibrium at the membrane or that
the incorporation of LCPUFA into phospholipids is
reduced at these initial stages of the disease. In any
case, it is likely that the extremely low capacity of
human brain to synthesize LCPUFA [50], especially
those of the n-3 series, critically limits the ability of
nerve cells to correct such membrane defects.
In summary, our present study demonstrates that
APP/BACE1 association is significantly favored, if
not promoted, by the physical microenvironment of
lipid rafts. The finding that lipid rafts microviscosity is
positively related to the degree of physical association
of APP and BACE1 in lipid rafts where cholesterol
levels are reduced, demonstrates essential role of n-3
LCPUFA in the biophysical properties of lipid rafts in
neuronal physiology. Understanding the mechanisms
leading to changes in lipid raft membrane’s biophysics
and how they affect APP processing, should provide
new clues for early detection and insights to tailoring
new therapeutic strategies for prevention and treatment
of AD.
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